Arizona 2025 Regular Session

Arizona Senate Bill SB1076 Compare Versions

Version 1 (Old)

Version 2 (New)

Old	New		Differences
1		-	~~Senate Engrossed~~ newborn screening; Duchenne muscular dystrophy State of Arizona Senate Fifty-seventh Legislature First Regular Session 2025 ~~SENATE BILL~~ 1076 AN ACT amending section 36-694, Arizona Revised Statutes; relating to the newborn screening program. (TEXT OF BILL BEGINS ON NEXT PAGE)
	1	+	REFERENCE TITLE: newborn screening; Duchenne muscular dystrophy State of Arizona Senate Fifty-seventh Legislature First Regular Session 2025 SB 1076 Introduced by Senators Shope: Carroll, Shamp; Representatives Bliss, Pingerelli AN ACT amending section 36-694, Arizona Revised Statutes; relating to the newborn screening program. (TEXT OF BILL BEGINS ON NEXT PAGE)
2	2
3	3
4	4
5	5
6	6
7	7
8	8
	9	+	REFERENCE TITLE: newborn screening; Duchenne muscular dystrophy
	10	+	State of Arizona Senate Fifty-seventh Legislature First Regular Session 2025
	11	+	SB 1076
	12	+	Introduced by Senators Shope: Carroll, Shamp; Representatives Bliss, Pingerelli
9	13
10		-
11		-	Senate Engrossed newborn screening; Duchenne muscular dystrophy
12		-	State of Arizona Senate Fifty-seventh Legislature First Regular Session 2025
13		-	SENATE BILL 1076
14		-
15		-	Senate Engrossed
16		-
17		-
18		-
19		-	newborn screening; Duchenne muscular dystrophy
	14	+	REFERENCE TITLE: newborn screening; Duchenne muscular dystrophy
20	15
21	16
22	17
23	18
24	19
25	20
26	21
27	22
28	23
29	24		State of Arizona
30	25
31	26		Senate
32	27
33	28		Fifty-seventh Legislature
34	29
35	30		First Regular Session
36	31
37	32		2025
38	33
39	34
40	35
41	36
42	37
43	38
44	39
45		-	SENATE BILL 1076
	40	+	SB 1076
	41	+
	42	+
	43	+
	44	+	Introduced by
	45	+
	46	+	Senators Shope: Carroll, Shamp; Representatives Bliss, Pingerelli
	47	+
	48	+
	49	+
	50	+
	51	+
	52	+
	53	+
	54	+
46	55
47	56
48	57
49	58
50	59
51	60
52	61
53	62
54	63
55	64		AN ACT
56	65
57	66
58	67
59	68		amending section 36-694, Arizona Revised Statutes; relating to the newborn screening program.
60	69
61	70
62	71
63	72
64	73
65	74		(TEXT OF BILL BEGINS ON NEXT PAGE)
66		-
67		-
68	75
69	76
70	77
71	78		Be it enacted by the Legislature of the State of Arizona: Section 1. Section 36-694, Arizona Revised Statutes, is amended to read: START_STATUTE36-694. Report of blood tests; newborn screening program; committee; fee; definitions A. When a birth or stillbirth is reported, the attending physician or other person required to report the birth shall state on the certificate whether a blood test for syphilis was made on a specimen of blood taken from the woman who bore the child or from the umbilical cord at delivery, as required by section 36-693, and the approximate date when the specimen was taken. B. When a birth is reported, the attending physician or person who is required to report the birth shall order or cause to be ordered tests for certain congenital disorders, including hearing disorders. The results of tests for these disorders must be reported to the department of health services. The department of health services shall specify in rule the disorders, the process for collecting and submitting specimens and the reporting requirements for test results. C. When a hearing test is performed on a newborn, the initial hearing test results and any subsequent hearing test results must be reported to the department of health services as prescribed by department rules. D. The director of the department of health services shall establish a newborn screening program within the department to ensure that the testing for congenital disorders and the reporting of hearing test results required by this section are conducted in an effective and efficient manner. The newborn screening program shall include all congenital disorders that are included on the recommended uniform screening panel adopted by the secretary of the United States department of health and human services for both core and secondary conditions. Beginning January 1, 2022, congenital disorders that are added to the core and secondary conditions list of the recommended uniform screening panel shall be added to this state's newborn screening panel within two years after their addition to the recommended uniform screening panel. The newborn screening program shall include an education program for the general public, the medical community, parents and professional groups. The director shall designate the state laboratory as the only testing facility for the program, except that the director may designate other laboratory testing facilities for conditions or tests added to the newborn screening program on or after July 24, 2014. If the director designates another laboratory testing facility for any condition or test, the director shall require the facility to follow all of the privacy and sample destruction time frames that are required of the state laboratory. E. In addition to the congenital disorders added to this state's newborn screening panel pursuant to subsection D of this section, the department shall add Duchenne muscular dystrophy to this state's newborn screening panel. E. F. The newborn screening program shall establish and maintain a central database of newborns and infants who are tested for hearing loss and congenital disorders that includes information required in rule. Test results are confidential subject to the disclosure provisions of sections 12-2801 and 12-2802. F. G. If tests conducted pursuant to this section indicate that a newborn or infant may have a hearing loss or a congenital disorder, the screening program shall provide follow-up services to encourage the child's family to access evaluation services, specialty care and early intervention services. G. H. The director shall establish a committee to provide recommendations and advice to the department on at least an annual basis regarding newborn screening best practices and emerging trends. H. I. The director may establish by rule a fee that the department may collect for operating the newborn screening program, including contracting for the testing pursuant to this section. The director shall present any change to the fee for the newborn screening program to the joint legislative budget committee for review. I. J. Not later than sixty days after the department adjusts the newborn screening program fee established pursuant to subsection H I of this section: 1. Each health insurer that is subject to title 20 shall update its hospital rates that include newborn screening to reflect the increase. 2. For the Arizona health care cost containment system and contractors acting pursuant to chapter 29, article 1 of this title that are not subject to title 20, the Arizona health care cost containment system shall update its hospital rates that include newborn screening to reflect the increase. J. K. For the purposes of this section: 1. "Infant" means a child who is twenty-nine days of age to two years of age. 2. "Newborn" means a child who is not more than twenty-eight days of age. END_STATUTE Sec. 2. Effective date; notification A. Section 36-694, Arizona Revised Statutes, as amended by this act, is effective the earlier of either of the following: 1. October 1, 2027. 2. Two years after the date Duchenne muscular dystrophy is added to the recommended uniform screening panel adopted by the secretary of the United States department of health and human services. B. The director of the department of health services shall notify the director of the Arizona legislative council in writing within ten days after the date that Duchenne muscular dystrophy is added to the recommended uniform screening panel adopted by the secretary of the United States department of health and human services.
72	79
73	80		Be it enacted by the Legislature of the State of Arizona:
74	81
75	82		Section 1. Section 36-694, Arizona Revised Statutes, is amended to read:
76	83
77	84		START_STATUTE36-694. Report of blood tests; newborn screening program; committee; fee; definitions
78	85
79	86		A. When a birth or stillbirth is reported, the attending physician or other person required to report the birth shall state on the certificate whether a blood test for syphilis was made on a specimen of blood taken from the woman who bore the child or from the umbilical cord at delivery, as required by section 36-693, and the approximate date when the specimen was taken.
80	87
81	88		B. When a birth is reported, the attending physician or person who is required to report the birth shall order or cause to be ordered tests for certain congenital disorders, including hearing disorders. The results of tests for these disorders must be reported to the department of health services. The department of health services shall specify in rule the disorders, the process for collecting and submitting specimens and the reporting requirements for test results.
82	89
83	90		C. When a hearing test is performed on a newborn, the initial hearing test results and any subsequent hearing test results must be reported to the department of health services as prescribed by department rules.
84	91
85	92		D. The director of the department of health services shall establish a newborn screening program within the department to ensure that the testing for congenital disorders and the reporting of hearing test results required by this section are conducted in an effective and efficient manner. The newborn screening program shall include all congenital disorders that are included on the recommended uniform screening panel adopted by the secretary of the United States department of health and human services for both core and secondary conditions. Beginning January 1, 2022, congenital disorders that are added to the core and secondary conditions list of the recommended uniform screening panel shall be added to this state's newborn screening panel within two years after their addition to the recommended uniform screening panel. The newborn screening program shall include an education program for the general public, the medical community, parents and professional groups. The director shall designate the state laboratory as the only testing facility for the program, except that the director may designate other laboratory testing facilities for conditions or tests added to the newborn screening program on or after July 24, 2014. If the director designates another laboratory testing facility for any condition or test, the director shall require the facility to follow all of the privacy and sample destruction time frames that are required of the state laboratory.
86	93
87	94		E. In addition to the congenital disorders added to this state's newborn screening panel pursuant to subsection D of this section, the department shall add Duchenne muscular dystrophy to this state's newborn screening panel.
88	95
89	96		E. F. The newborn screening program shall establish and maintain a central database of newborns and infants who are tested for hearing loss and congenital disorders that includes information required in rule. Test results are confidential subject to the disclosure provisions of sections 12-2801 and 12-2802.
90	97
91	98		F. G. If tests conducted pursuant to this section indicate that a newborn or infant may have a hearing loss or a congenital disorder, the screening program shall provide follow-up services to encourage the child's family to access evaluation services, specialty care and early intervention services.
92	99
93	100		G. H. The director shall establish a committee to provide recommendations and advice to the department on at least an annual basis regarding newborn screening best practices and emerging trends.
94	101
95	102		H. I. The director may establish by rule a fee that the department may collect for operating the newborn screening program, including contracting for the testing pursuant to this section. The director shall present any change to the fee for the newborn screening program to the joint legislative budget committee for review.
96	103
97	104		I. J. Not later than sixty days after the department adjusts the newborn screening program fee established pursuant to subsection H I of this section:
98	105
99	106		1. Each health insurer that is subject to title 20 shall update its hospital rates that include newborn screening to reflect the increase.
100	107
101	108		2. For the Arizona health care cost containment system and contractors acting pursuant to chapter 29, article 1 of this title that are not subject to title 20, the Arizona health care cost containment system shall update its hospital rates that include newborn screening to reflect the increase.
102	109
103	110		J. K. For the purposes of this section:
104	111
105	112		1. "Infant" means a child who is twenty-nine days of age to two years of age.
106	113
107	114		2. "Newborn" means a child who is not more than twenty-eight days of age. END_STATUTE
108	115
109	116		Sec. 2. Effective date; notification
110	117
111	118		A. Section 36-694, Arizona Revised Statutes, as amended by this act, is effective the earlier of either of the following:
112	119
113	120		1. October 1, 2027.
114	121
115	122		2. Two years after the date Duchenne muscular dystrophy is added to the recommended uniform screening panel adopted by the secretary of the United States department of health and human services.
116	123
117	124		B. The director of the department of health services shall notify the director of the Arizona legislative council in writing within ten days after the date that Duchenne muscular dystrophy is added to the recommended uniform screening panel adopted by the secretary of the United States department of health and human services.